Natera is a leading molecular diagnostics company based in San Carlos, CA. They specialize in providing noninvasive cell-free DNA tests that help inform personalized healthcare decisions. Their tests measure fetal, tumor, or donor cfDNA at the molecular level, allowing for the identification of disease risk, detection of recurrence, and understanding of treatment responses. Natera is dedicated to advancing healthcare in the fields of oncology, women's health, and organ health, offering innovative solutions that enable more informed health decisions for individualized care.
With a commitment to integrity and scientific rigor, Natera is at the forefront of molecular diagnostics innovation. Their oncology tests allow for the characterization of tumors, anticipation of risk, and evaluation of treatment response earlier than traditional tools. In the field of women's health, Natera's tests help identify the risk of severe genetic conditions, enabling families to prepare and inform early intervention for improved outcomes. Additionally, their organ health tests detect organ injury early and inform treatment strategies to enhance transplant health. Natera's dedication to innovation and integrity sets them apart as a trusted provider of molecular diagnostic solutions.
Generated from the website